Tempus stated that patients can, for example, ask olivia to summarise their overall health status. Image credit: SkillUp via Shutterstock.

Tempus AI has launched olivia in the US, an app designed for centralising patient healthcare data onto a unified platform that uses AI to provide actionable insights.

Patients can use the app to consolidate electronic health records (EHR), data from digital health devices, or manually uploaded health records onto one unified platform. Olivia then organises the data into a timeline for patients to access healthcare records such as lab results, imaging reports, and hospital or general practitioner visit summaries.

Go deeper with GlobalData

Data Insights

The gold standard of business intelligence.

Find out more

The app can also connect to external resources to further supplement existing health data.

With the app’s AI provision, users can ask questions about their records, summarise their health information, and receive responses informed by their data.

Chicago-based Tempus stated that patients can, for example, ask olivia to summarise their overall health status. By running AI on the data available, the app can generate a summary in response to such questions.

Tempus founder and CEO Eric Lefkofsky commented: “Now, as AI becomes increasingly integrated into healthcare, tools like olivia will be essential in helping patients understand and navigate their care.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

“This app goes beyond organising information; it’s a proactive partner empowering patients to steer their health with confidence and clarity.”

A report by GlobalData forecasts that every segment of the AI market in healthcare will experience growth over the next decade, increasing from a value of around $103bn in 2023 to over $1tn by 2033.

This month, tempus’s generative AI (genAI) assistant, Tempus One, launched a range of new capabilities for running queries on millions of unstructured documents for research and clinical care.

In November 2024, the Nasdaq-listed company signed a $600m deal to acquire Ambry Genetics to bolster its analytic capabilities in healthcare. In June, Tempus gained 510(k) clearance from the FDA for Tempus ECG-AF, a device intended to help identify patients at an increased risk of atrial fibrillation or flutter.